Literature DB >> 32430501

Phenotype and Natural History of Inflammatory Bowel Disease in Patients With Concomitant Eosinophilic Esophagitis.

Michael J Mintz1, Ashwin N Ananthakrishnan1,2.   

Abstract

BACKGROUND: The co-occurrence of autoimmune diseases is well recognized. Though studies have suggested that eosinophilic esophagitis (EoE) is more common in patients with inflammatory bowel diseases (IBD), whether co-occurrence of EoE modifies natural history of IBD is unknown.
METHODS: This was a retrospective case-control study at a referral center. Cases consisted of patients with IBD and EoE, with both diseases diagnosed using established criteria. Controls comprised patients with IBD without concomitant EoE. Two controls were selected per case and were matched for duration of IBD. Relevant covariates regarding disease presentation and natural history were extracted from the medical record and compared between the 2 groups.
RESULTS: A total of 95 IBD-EoE cases and 190 IBD controls were included in our study. The IBD-EoE group was diagnosed with IBD at a younger age than those with IBD alone (22.3 years vs 29.0 years; P < 0.001) and were more likely to be male (80.0% vs 45.8%; P < 0.001). There were no differences in medical or surgical therapy for IBD between the 2 groups. Among those with IBD-EoE, patients for whom IBD was diagnosed first presented more commonly with dysphagia (50.8% vs 26.9%; P = 0.04) and endoscopically had evidence of esophageal rings (50.0% vs 23.1%; P = 0.02) when compared with those where EoE was diagnosed first.
CONCLUSION: Patients with concurrent IBD-EoE are diagnosed at a younger age and more likely to be males but have similar natural history as those without EoE. There were differences in EoE phenotype based on whether the EoE or IBD was diagnosed first.
© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  disease co-occurrence; eosinophilic esophagitis; inflammatory bowel disease

Mesh:

Year:  2021        PMID: 32430501      PMCID: PMC7957221          DOI: 10.1093/ibd/izaa094

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  42 in total

Review 1.  Epidemiology and Natural History of Eosinophilic Esophagitis.

Authors:  Evan S Dellon; Ikuo Hirano
Journal:  Gastroenterology       Date:  2017-08-01       Impact factor: 22.682

Review 2.  The genomic landscape of human immune-mediated diseases.

Authors:  Xin Wu; Haiyan Chen; Huji Xu
Journal:  J Hum Genet       Date:  2015-08-20       Impact factor: 3.172

Review 3.  Eosinophilic esophagitis in adults: a systematic review.

Authors:  Spiros N Sgouros; Christina Bergele; Apostolos Mantides
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-02       Impact factor: 2.566

Review 4.  Molecular, genetic, and cellular bases for treating eosinophilic esophagitis.

Authors:  Marc E Rothenberg
Journal:  Gastroenterology       Date:  2015-02-07       Impact factor: 22.682

5.  Inflammatory bowel disease: an update on the fundamental biology and clinical management.

Authors:  Richard Blumberg; Judy Cho; James Lewis; Gary Wu
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

6.  PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.

Authors:  E V Loftus; G C Harewood; C G Loftus; W J Tremaine; W S Harmsen; A R Zinsmeister; D A Jewell; W J Sandborn
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

7.  Differential effect of genetic burden on disease phenotypes in Crohn's disease and ulcerative colitis: analysis of a North American cohort.

Authors:  Ashwin N Ananthakrishnan; Hailiang Huang; Deanna D Nguyen; Jenny Sauk; Vijay Yajnik; Ramnik J Xavier
Journal:  Am J Gastroenterol       Date:  2014-01-14       Impact factor: 10.864

8.  Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case-control study within LUMINA, a multiethnic US cohort (LUMINA LVII).

Authors:  L B Tucker; A G Uribe; M Fernández; L M Vilá; G McGwin; M Apte; B J Fessler; H M Bastian; J D Reveille; G S Alarcón
Journal:  Lupus       Date:  2008-04       Impact factor: 2.911

9.  A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease.

Authors:  Eleonora A M Festen; Philippe Goyette; Todd Green; Gabrielle Boucher; Claudine Beauchamp; Gosia Trynka; Patrick C Dubois; Caroline Lagacé; Pieter C F Stokkers; Daan W Hommes; Donatella Barisani; Orazio Palmieri; Vito Annese; David A van Heel; Rinse K Weersma; Mark J Daly; Cisca Wijmenga; John D Rioux
Journal:  PLoS Genet       Date:  2011-01-27       Impact factor: 5.917

10.  Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.

Authors:  Morten L Halling; Jens Kjeldsen; Torben Knudsen; Jan Nielsen; Lars Koch Hansen
Journal:  World J Gastroenterol       Date:  2017-09-07       Impact factor: 5.742

View more
  3 in total

1.  Comorbid Diagnosis of Eosinophilic Esophagitis and Inflammatory Bowel Disease in the Pediatric Population.

Authors:  Hillary Moore; Joshua Wechsler; Carrie Frost; Elizabeth Whiteside; Robert Baldassano; Jonathan Markowitz; Amanda B Muir
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288

2.  Eosinophilic gastrointestinal disorders in patients with inborn errors of immunity: Data from the USIDNET registry.

Authors:  Paulina Tran; Laura Gober; Elizabeth K Garabedian; Ramsay L Fuleihan; Jennifer M Puck; Kathleen E Sullivan; Jonathan M Spergel; Melanie A Ruffner
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

Review 3.  Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls.

Authors:  Bence Kővári; Rish K Pai
Journal:  Adv Anat Pathol       Date:  2022-01-01       Impact factor: 3.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.